Abstract:Abstract MicroRNAs (miRNAs) are small non coding RNAs of about 22 nucleotides in length, which regulate their target gene expression by binding to the 3′ UTR of mRNA. Recent studies have shown that some miRNAs are regulated by DNA methylation and aberrant miRNA gene methylation contributes to human tumorigenesis. In this study, we used real-time quantitative methylation-specific PCR to detect a panel of miRNA methylation in tumor and adjacent normal tissues from surgically resected lung cancer patients. We found significantly higher methylation levels of miR-124a family, miR-126, miR-193a, miR-9 family, and miR-34b/c in tumor tissues (N=107) than in normal tissues (N=19, P<0.05), but no significant difference was found for miRNA-137 and miRNA-148a. The methylation levels of four miRNAs (miRNA-124a3, miRNA-148a, miR-9-3, and miR-34b/c) were higher in tumors from older patients than those from younger patients. MiR-9-1 (29.56±29.51) and miR-9-3 (30.49±28.50) had higher methylation in tumors from current smokers than never smokers (15.77±15.28 and 10.71±11.32, P=0.036 and 0.021, respectively). There were no significant differences in methylation levels of these four miRNAs between tumors from men and women. Hypermethylation of miR-9-1, miR-9-3, miR-34b/c and miR-148a was associated with significantly better survival with hazard rations of 0.35 (95% CI, 0.17-0.72), 0.48 (95% CI, 0.25-0.91), 0.52 (95% CI, 0.27-0.99), and 0.52 (95% CI, 0.28-0.98), respectively. Our results demonstrated that selected miRNAs are hypermethylated in lung cancer and miRNA hypermethylation might be a useful biomarker in detection and prognosis of lung cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4092.

Supplementary Table 2 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Table 4 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Table 3 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Table 1 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Figure 1 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Figure 5 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer.

Supplementary Figure 4 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Genome-wide Methylation Profiling Reveals Differentially Methylated Genes in Blood DNA of Small-Cell Lung Cancer Patients

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Tables 1-8 from Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Gene Regulation and Prognostic Indicators of Lung Squamous Cell Carcinoma: TCGA-derived Mirna/mrna Sequencing and DNA Methylation Data.

Supplementary Table 1 from Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem–like Cell Traits in Breast Cancer

Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.

DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non–Small Cell Lung Cancer Patients

Aberrant Mirna Methylation In Tumors From Surgically Resected Lung Cancer Patients And Association With Survival

Supplementary Methods, Figure Legends, Tables 1 - 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Methylated DNA immunoprecipitation combined with microarray (MeDIP-chip) v2

Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer